Palbociclib in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer: A Systematic Scoping Review of Real-World Evidence from Countries Outside of Western Regions that Are Underrepresented in Clinical Trials.

Rauthan, Amit; Jain, Ankita; Singh, Manmohan; Sendur, Mehmet A N

Rauthan, Amit; Jain, Ankita; Singh, Manmohan; Sendur, Mehmet A N.

Afiliação

Rauthan A; Department of Medical Oncology, Manipal Hospital, Bengaluru, India.
Jain A; Medical Affairs Oncology and Field Medical Excellence, Regional Medical Affairs, Pfizer Healthcare India Private Limited, The Capital, 1802/1901, Plot No. C-70, G-Block, Bandra Kurla Complex, Bandra (E), Mumbai, 400 051, India. Ankita.Jain@pfizer.com.
Singh M; Regional Medical Affairs, Pfizer Corporation Hong Kong Limited, Hong Kong, Hong Kong.
Sendur MAN; Department of Medical Oncology, Faculty of Medicine and Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey.

Oncol Ther ; 12(3): 395-418, 2024 Sep.

Article em En | MEDLINE | ID: mdl-39095679